Skip to main content
Erschienen in: Intensive Care Medicine 3/2017

06.08.2016 | Understanding the Disease

Understanding biofilm formation in intravascular device-related infections

verfasst von: Christophe Beloin, Nuria Fernández-Hidalgo, David Lebeaux

Erschienen in: Intensive Care Medicine | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Excerpt

The use of indwelling devices is constantly increasing in modern medicine. Although they improve patients’ care, it is recognised that their use is associated with the risk of infection. Device-related infections represent a significant part of hospital-acquired infections and are due to device contamination by microorganisms subsequently forming biofilms. These biofilms are formed by sessile communities encased in a self-produced matrix that protects them from external insults including the host immune system and antimicrobial agents. Historically the first description of the involvement of biofilms in a device-related infection was provided in 1982 by the observation of a pacemaker colonised by Staphylococcus aureus [1]. Since then, formation of biofilms has been described in all indwelling devices and is especially problematic in intensive care units (ICU) where intravascular devices are extensively used and critically ill patients may require the concomitant use of several devices. In part because of their repeated manipulation, the use of such devices is associated with bloodstream infection incidence densities ranging from 0.8 to 3.7 episodes per 1000 catheter-days, depending on the definitions used, ICU units, and infection control practices [2]. Main microorganisms responsible for intravascular catheter colonisation and subsequent infections depend on local epidemiology and type of ICU but mostly include Staphylococcus spp., Gram-negative rods and yeasts. …
Literatur
1.
Zurück zum Zitat Marrie TJ, Nelligan J, Costerton JW (1982) A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation 66:1339–1341CrossRefPubMed Marrie TJ, Nelligan J, Costerton JW (1982) A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation 66:1339–1341CrossRefPubMed
2.
Zurück zum Zitat Dudeck MA, Horan TC, Peterson KD, Allen-Bridson K, Morrell G, Anttila A, Pollock DA, Edwards JR (2013) National Healthcare Safety Network report, data summary for 2011, device-associated module. Am J Infect Control 41:286–300CrossRefPubMedPubMedCentral Dudeck MA, Horan TC, Peterson KD, Allen-Bridson K, Morrell G, Anttila A, Pollock DA, Edwards JR (2013) National Healthcare Safety Network report, data summary for 2011, device-associated module. Am J Infect Control 41:286–300CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C (2006) An intervention to decrease catheter-related bloodstream infections in the ICU. New Engl J Med 355:2725–2732CrossRefPubMed Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C (2006) An intervention to decrease catheter-related bloodstream infections in the ICU. New Engl J Med 355:2725–2732CrossRefPubMed
4.
Zurück zum Zitat Chagnot C, Zorgani MA, Astruc T, Desvaux M (2013) Proteinaceous determinants of surface colonization in bacteria: bacterial adhesion and biofilm formation from a protein secretion perspective. Front Microbiol 4:303CrossRefPubMedPubMedCentral Chagnot C, Zorgani MA, Astruc T, Desvaux M (2013) Proteinaceous determinants of surface colonization in bacteria: bacterial adhesion and biofilm formation from a protein secretion perspective. Front Microbiol 4:303CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Valentini M, Filloux A (2016) Biofilms and cyclic di-GMP (c-di-GMP) signaling: lessons from Pseudomonas aeruginosa and other bacteria. J Biol Chem 291:12547–12555CrossRefPubMedPubMedCentral Valentini M, Filloux A (2016) Biofilms and cyclic di-GMP (c-di-GMP) signaling: lessons from Pseudomonas aeruginosa and other bacteria. J Biol Chem 291:12547–12555CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S, Friggeri A, Wallet F, Allou N, Ruckly S, Balayn D, Lepape A, Timsit JF, CLEAN trial investigators (2015) Skin antisepsis with chlorhexidine–alcohol versus povidone iodine–alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 386:2069–2077CrossRefPubMed Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S, Friggeri A, Wallet F, Allou N, Ruckly S, Balayn D, Lepape A, Timsit JF, CLEAN trial investigators (2015) Skin antisepsis with chlorhexidine–alcohol versus povidone iodine–alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 386:2069–2077CrossRefPubMed
7.
Zurück zum Zitat Schwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, Timsit JF (2012) Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the dressing study. Crit Care Med 40:11–17CrossRefPubMed Schwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, Timsit JF (2012) Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the dressing study. Crit Care Med 40:11–17CrossRefPubMed
8.
Zurück zum Zitat Batoni G, Maisetta G, Esin S (2016) Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria. Biochim Biophys Acta 1858:1044–1060CrossRefPubMed Batoni G, Maisetta G, Esin S (2016) Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria. Biochim Biophys Acta 1858:1044–1060CrossRefPubMed
9.
Zurück zum Zitat Souweine B, Lautrette A, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Cointault O, Lepape A, Guelon D, Darmon M, Vesin A, Caillot N, Schwebel C, Boyer A, Azoulay E, Bouadma L, Timsit JF (2015) Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial. Am J Respir Crit Care Med 191:1024–1032CrossRefPubMed Souweine B, Lautrette A, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Cointault O, Lepape A, Guelon D, Darmon M, Vesin A, Caillot N, Schwebel C, Boyer A, Azoulay E, Bouadma L, Timsit JF (2015) Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial. Am J Respir Crit Care Med 191:1024–1032CrossRefPubMed
10.
Zurück zum Zitat Chauhan A, Bernardin A, Mussard W, Kriegel I, Esteve M, Ghigo JM, Beloin C, Semetey V (2014) Preventing biofilm formation and associated occlusion by biomimetic glycocalyx like polymer in central venous catheters. J Infect Dis 210:1347–1356CrossRefPubMed Chauhan A, Bernardin A, Mussard W, Kriegel I, Esteve M, Ghigo JM, Beloin C, Semetey V (2014) Preventing biofilm formation and associated occlusion by biomimetic glycocalyx like polymer in central venous catheters. J Infect Dis 210:1347–1356CrossRefPubMed
11.
Zurück zum Zitat Junter GA, Thebault P, Lebrun L (2016) Polysaccharide-based antibiofilm surfaces. Acta Biomater 30:13–25CrossRefPubMed Junter GA, Thebault P, Lebrun L (2016) Polysaccharide-based antibiofilm surfaces. Acta Biomater 30:13–25CrossRefPubMed
12.
Zurück zum Zitat Sambanthamoorthy K, Luo C, Pattabiraman N, Feng X, Koestler B, Waters CM, Palys TJ (2014) Identification of small molecules inhibiting diguanylate cyclases to control bacterial biofilm development. Biofouling 30:17–28CrossRefPubMed Sambanthamoorthy K, Luo C, Pattabiraman N, Feng X, Koestler B, Waters CM, Palys TJ (2014) Identification of small molecules inhibiting diguanylate cyclases to control bacterial biofilm development. Biofouling 30:17–28CrossRefPubMed
13.
Zurück zum Zitat Stewart PS, Franklin MJ (2008) Physiological heterogeneity in biofilms. Nat Rev Microbiol 6:199–210CrossRefPubMed Stewart PS, Franklin MJ (2008) Physiological heterogeneity in biofilms. Nat Rev Microbiol 6:199–210CrossRefPubMed
14.
Zurück zum Zitat Lebeaux D, Ghigo JM, Beloin C (2014) Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 78:510–543CrossRefPubMedPubMedCentral Lebeaux D, Ghigo JM, Beloin C (2014) Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 78:510–543CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1–45CrossRefPubMedPubMedCentral Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1–45CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Planes AM, Calleja R, Bernet A, Campins-Marti M, Almirante B, Pumarola T, Fernandez-Hidalgo N (2016) Evaluation of the usefulness of a quantitative blood culture in the diagnosis of catheter-related bloodstream infection: Comparative analysis of two periods (2002 and 2012). Enferm Infecc Microbiol Clin. doi:10.1016/j.eimc.2015.11.007 Planes AM, Calleja R, Bernet A, Campins-Marti M, Almirante B, Pumarola T, Fernandez-Hidalgo N (2016) Evaluation of the usefulness of a quantitative blood culture in the diagnosis of catheter-related bloodstream infection: Comparative analysis of two periods (2002 and 2012). Enferm Infecc Microbiol Clin. doi:10.​1016/​j.​eimc.​2015.​11.​007
17.
Zurück zum Zitat Fernandez-Hidalgo N, Almirante B (2014) Antibiotic-lock therapy: a clinical viewpoint. Expert Rev Anti-infective Ther 12:117–129CrossRef Fernandez-Hidalgo N, Almirante B (2014) Antibiotic-lock therapy: a clinical viewpoint. Expert Rev Anti-infective Ther 12:117–129CrossRef
18.
Zurück zum Zitat Chauhan A, Lebeaux D, Ghigo JM, Beloin C (2012) Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob Agents Chemother 56:6310–6318CrossRefPubMedPubMedCentral Chauhan A, Lebeaux D, Ghigo JM, Beloin C (2012) Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob Agents Chemother 56:6310–6318CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Beloin C, Renard S, Ghigo JM, Lebeaux D (2014) Novel approaches to combat bacterial biofilms. Curr Opin Pharmacol 18:61–68CrossRefPubMed Beloin C, Renard S, Ghigo JM, Lebeaux D (2014) Novel approaches to combat bacterial biofilms. Curr Opin Pharmacol 18:61–68CrossRefPubMed
Metadaten
Titel
Understanding biofilm formation in intravascular device-related infections
verfasst von
Christophe Beloin
Nuria Fernández-Hidalgo
David Lebeaux
Publikationsdatum
06.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 3/2017
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-016-4480-7

Weitere Artikel der Ausgabe 3/2017

Intensive Care Medicine 3/2017 Zur Ausgabe

What's New in Intensive Care

Does this patient have septic shock?

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.